Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance
The Pharma Data
AUGUST 3, 2021
Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent business development. “We delivered strong performance this quarter, with volume-driven growth across our core business and most major geographies. on a non-GAAP basis.
Let's personalize your content